Article
Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models.
Developmental cell - 28 Mar 2022
Cha Sun Joo, Lee Seongsoo, Choi Hyun-Jun, Han Yeo Jeong, Jeon Yu-Mi, Jo Myungjin, Lee Shinrye, Nahm Minyeop, Lim Su Min, Kim Seung Hyun, Kim Hyung-Jun, Kim Kiyoung
Abstract excerpt
Fused in sarcoma (FUS) is a DNA/RNA-binding protein that is involved in DNA repair and RNA processing. FUS is associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, the molecular mechanisms underlying FUS-mediated neurodegeneration are largely unknown. Here, using a Drosophila model, we showed that the overexpression of glutathione...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
